Mirabella Financial Services LLP Vir Biotechnology, Inc. Transaction History

Mirabella Financial Services LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$23.2 - $27.29 $9.56 Million - $11.2 Million	412,008 New	412,008 $10.1 Million
Q2 2022 Aug 12, 2022	SELL	$19.08 - $26.7 $1.17 Million - $1.63 Million	-61,137 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$21.19 - $40.01 $1.3 Million - $2.45 Million	61,137 New	61,137 $1.57 Million
Q4 2020 Feb 16, 2021	SELL	$25.51 - $43.38 $743,106 - $1.26 Million	-29,130 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$28.28 - $53.6 $823,796 - $1.56 Million	29,130 New	29,130 $1 Million

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.